Physician profile
Boo Ghee Low
NPI 1629024955
$25,267.45
in general payments reported to CMS, 2019-2025
76 companies · $831 in 2025
The $831 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,309 · 2020: $2,020 · 2021: $3,251 · 2022: $4,177 · 2023: $5,435 · 2024: $6,244 · 2025: $831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Long Term Medical Supply Or Device Loan: $732 · Education: $473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,303.96 |
| Long Term Medical Supply Or Device Loan | $732.12 |
| Education | $473.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,439.63 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $1,949.49 | 2019-2025 | Tagrisso, Imfinzi, Lynparza |
| Genentech USA, INC. | $1,363.29 | 2019-2025 | Alecensa, Tecentriq, Phesgo |
| Janssen Biotech, INC. | $1,338.48 | 2019-2025 | Darzalex, Rybrevant, Tecvayli |
| Merck Sharp & Dohme LLC | $1,229.00 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Pfizer INC. | $1,083.12 | 2019-2024 | |
| Amgen INC. | $1,083.07 | 2019-2024 | Kyprolis, Xgeva, Vectibix |
| E.R. Squibb & Sons, L.L.C. | $1,015.71 | 2019-2025 | Opdivo, Opdualag, Pomalyst |
| Seagen INC. | $1,011.86 | 2019-2023 | Adcetris, Tukysa, Padcev |
| Astellas Pharma US INC | $876.28 | 2019-2024 | Xospata, Padcev, Xtandi |
| Lilly USA, LLC | $872.72 | 2019-2024 | Retevmo, Verzenio, Jaypirca |
| Genzyme Corporation | $807.09 | 2019-2024 | |
| Celgene Corporation | $735.74 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Daiichi Sankyo INC. | $613.94 | 2019-2024 | Enhertu, Injectafer, Vanflyta |
| Abbvie INC. | $528.31 | 2019-2025 |
Show all 76 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $518.05 | 2019-2023 | |
| Glaxosmithkline, LLC. | $395.88 | 2020-2025 | Zejula, Ojjaara, Shingrix |
| Alexion Pharmaceuticals, INC. | $363.12 | 2019-2024 | Ultomiris |
| Emd Serono, INC. | $344.66 | 2019-2024 | Bavencio, Tepmetko |
| Ipsen Biopharmaceuticals, INC | $338.38 | 2019-2025 | Onivyde, Somatuline Depot, Tazverik |
| Sumitomo Pharma America, INC. | $337.14 | 2024-2025 | Orgovyx |
| Pharmacyclics LLC, An Abbvie Company | $336.28 | 2019-2023 | Imbruvica, Epkinly |
| Eisai INC. | $328.57 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $291.47 | 2019-2025 | Fruzaqla, Alunbrig, Vpriv |
| Incyte Corporation | $280.04 | 2019-2025 | Jakafi |
| Regeneron Healthcare Solutions, INC. | $279.18 | 2019-2024 | Libtayo |
| Gilead Sciences, INC. | $272.85 | 2021-2025 | Trodelvy |
| Sobi, INC | $249.91 | 2022-2024 | |
| Array Biopharma INC | $242.11 | 2021-2024 | Braftovi, Mektovi, Lorbrena |
| Puma Biotechnology, INC. | $214.41 | 2019-2024 | Nerlynx |
| Adaptive Biotechnologies Corporation | $213.92 | 2022-2024 | Clonoseq |
| Blueprint Medicines Corporation | $212.25 | 2021-2025 | Ayvakit |
| Exelixis INC. | $208.45 | 2019-2024 | Cabometyx |
| Kyowa Kirin, INC. | $182.82 | 2019-2025 | Poteligeo |
| Rigel Pharmaceuticals, INC. | $164.79 | 2019-2024 | Rezlidhia, Tavalisse |
| Clovis Oncology, INC. | $161.35 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $161.31 | 2019-2024 | |
| Sun Pharmaceutical Industries INC. | $146.91 | 2019-2023 | Yonsa, Odomzo |
| Caris Mpi, INC. | $140.18 | 2025 | Mi Cancer Seek |
| Adc Therapeutics America, INC. | $131.07 | 2022-2024 | |
| Tersera Therapeutics LLC | $122.85 | 2024 | Zoladex |
| Aveo Pharmaceuticals, INC. | $112.68 | 2022-2024 | Fotivda |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.87 | 2019-2024 | |
| Cti Biopharma Corp. | $108.26 | 2022-2023 | Vonjo |
| Taiho Oncology, INC. | $92.71 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $84.99 | 2022 | |
| Beigene USA, INC. | $82.73 | 2023-2024 | Brukinsa |
| Karyopharm Therapeutics INC. | $72.58 | 2022-2024 | Xpovio |
| Coherus Oncology, INC. | $71.05 | 2024-2025 | Loqtorzi |
| Servier Pharmaceuticals LLC | $69.34 | 2024 | |
| Agios Pharmaceuticals, INC. | $61.14 | 2019-2024 | Pyrukynd |
| Mylan Institutional INC. | $57.33 | 2019 | |
| Morphosys, US INC. | $56.56 | 2021-2023 | Monjuvi |
| Verastem, INC. | $54.18 | 2019-2020 | |
| Genmab U.S., INC. | $53.48 | 2023-2024 | Tivdak |
| Macrogenics, INC. | $53.40 | 2022 | |
| Mirati Therapeutics, INC. | $50.29 | 2023-2024 | Krazati |
| Global Blood Therapeutics, INC. | $48.72 | 2021-2022 | |
| Aurobindo Pharma USA, INC. | $43.90 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $41.91 | 2019 | |
| Pharmaessentia USA Corporation | $40.04 | 2023-2025 | Besremi |
| Deciphera Pharmaceuticals INC. | $38.97 | 2023-2024 | Qinlock |
| Tesaro, INC. | $35.43 | 2019 | |
| Tempus Ai, INC | $29.47 | 2024 | Xt Cdx |
| Janssen Pharmaceuticals, INC | $22.92 | 2019-2021 | |
| Progenics Pharmaceuticals, INC. | $22.75 | 2023 | Pylarify |
| Springworks Therapeutics, INC. | $21.84 | 2024 | Ogsiveo |
| Csl Behring | $20.17 | 2022 | |
| G1 Therapeutics, INC. | $18.85 | 2022 | |
| Stemline Therapeutics INC. | $18.31 | 2024 | Orserdu |
| Kite Pharma, INC. | $17.07 | 2022 | |
| Organon LLC | $16.57 | 2022 | |
| Tg Therapeutics, INC. | $14.30 | 2021 | |
| Myovant Sciences INC. | $14.03 | 2021 | |
| Catalyst Pharmaceuticals, INC. | $13.59 | 2023 | Firdapse |
| Foundation Medicine, INC. | $12.34 | 2020 |
Drugs and devices associated with these payments
Kisqali $671Keytruda $579Orgovyx $470Imbruvica $393Lynparza $343Tagrisso $340Opdivo $332Alecensa $301Venclexta $263Epkinly $257Tecentriq $252Imfinzi $237Enhertu $234Lenvima $234Phesgo $231Ultomiris $220Retevmo $210Reblozyl $206Xtandi $203Lunsumio $202Clonoseq $197Polivy $193Pomalyst $189Libtayo $178Rozlytrek $178Verzenio $173Columvi $170Darzalex $170Jaypirca $146Gavreto $146Lorbrena $142Pluvicto $141Perjeta $141Mi Cancer Seek $140Tukysa $137Doptelet $137Braftovi $131Mektovi $131Rybrevant $126Piqray $123Poteligeo $123Zoladex $123Ibrance $121Scemblix $116Adcetris $116Vonjo $115Talzenna $111Comirnaty $111Ayvakit $111Tecvayli $109Vitrakvi $108Stivarga $108Cablivi $107Enjaymo $107Opdualag $107Injectafer $97.39Lutathera $97.22Padcev $96.48Fotivda $96.45Onivyde $91.32Erleada $88.40Xalkori $86.34Bavencio $84.82Paxlovid $83.95Zejula $83.16Brukinsa $82.73Inlyta $79.73Itovebi $77.97Sarclisa $76.21Jakafi $76.09Kyprolis $73.08Welireg $70.86Tavalisse $69.33Rezlidhia $69.33Fabhalta $68.42Odomzo $66.86Yonsa $66.86Avastin $63.78Fruzaqla $59.50Trodelvy $57.66Ojjaara $57.06Shingrix $54.33Xospata $54.29Mekinist $53.71Tivdak $53.48Nplate $50.63Vectibix $50.63Xgeva $50.63Somatuline Depot $50.57Krazati $50.29Tasigna $49.44Loqtorzi $49.00Alunbrig $47.52Jemperli $47.45Gazyva $46.86Zepzelca $46.50Nubeqa $46.47Xofigo $46.47Tabrecta $46.41Tibsovo $46.24
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boo Ghee Low listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.